Merck & Co. Inc. (MRK) 10-Q Filing 2026-03-31

📊 Key Financial Highlights

Revenue

N/A

2026-03-31

Net Income

$3.72B

2026-03-31

EPS (Basic)

$0.01

Per share

Total Assets

$4.31T

Balance sheet

Operating Cash Flow

$16.48B

Cash flow statement

Gross Margin

N/A

Profitability

📋 Filing Information

Company	Merck & Co. Inc.
Ticker	MRK
Form Type	10-Q
Period of Report	2026-03-31
Filing Date	2026-04-29
Sector	Healthcare
CIK Number	0000310522

📄 View Full SEC Filing →

📝 Filing Summary

            This is a Quarterly Report (10-Q) filed by Merck & Co. Inc. with the SEC. It covers the quarter ending 2026-03-31 and includes unaudited financial statements and management discussion.
        

Merck & Co. Inc. (MRK) operates in the Healthcare sector. The company reported revenue of N/A and net income of $3.72B for the period ending 2026-03-31. The filing was submitted to the Securities and Exchange Commission (SEC) on 2026-04-29.

Investors and analysts use 10-Q filings to assess financial health, identify trends, and make investment decisions. Key areas to review include revenue growth, profit margins, cash flow generation, and management's outlook.

🔗 Explore More on emfls.github.io

Discover more financial analysis and guides:

🇰🇷 Korean Stock Analysis ₿ Crypto Reports 📊 All SEC Filings ✈️ Travel Guides 🎮 QuickPlay Arcade